|
End-of-day quote
2026-09-30
|
5-day change
|
1st Jan Change
|
|
4.760 CNY
|
+1.49%
|
 |
+1.06%
|
-8.81%
|
|
08-24 |
Northeast Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2026
|
CI
| |
06-15 |
Northeast Pharmaceutical Group Co., Ltd. Announces Final Cash Dividend on A Shares for 2025, Payable on 23 June 2026
|
CI
| |
04-27 |
Northeast Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026
|
CI
| |
04-02 |
Northeast Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2025
|
CI
| |
04-01 |
Northeast Pharmaceutical Group Co., Ltd. announces Annual dividend, payable on June 23, 2026
|
CI
| |
25-10-27 |
Northeast Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2025
|
CI
| |
25-10-09 |
Northeast Pharmaceutical Unit Gets Clinical Trial Approval for Glioma Treatment
|
MT
| |
25-09-08 |
Northeast Pharmaceutical Appoints CFO
|
MT
| |
25-09-02 |
Northeast Pharmaceutical CFO Resigns
|
MT
| |
25-08-26 |
Northeast Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2025
|
CI
| |
25-06-05 |
Northeast Pharmaceutical Gets Nod to Market Antiobiotic in Europe
|
MT
| |
25-04-28 |
Northeast Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2025
|
CI
| |
25-04-25 |
Northeast Pharmaceutical Group Co., Ltd. Announces Directorate Appointments
|
CI
| |
25-04-25 |
Northeast Pharmaceutical Group Co., Ltd. Approves Cash Dividend on (A Shares) for 2024, Payable on 23 June 2025
|
CI
| |
25-04-17 |
Northeast Pharmaceutical's Subsidiary Gets Nod to Market Levocarnitine Oral Solution
|
MT
| |
25-04-03 |
Northeast Pharmaceutical Group Co., Ltd. Proposes Final Cash Dividend for the Year 2024
|
CI
| |
25-04-02 |
Northeast Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2024
|
CI
| |
25-02-17 |
Northeast Pharmaceutical Gets Nod to Market HIV Raw Drug Material
|
MT
| |
25-01-22 |
Northeast Pharmaceutical Group Names Chair
|
MT
| |
25-01-09 |
Northeast Pharma to Donate 10 Million Yuan in Goods to Tibet's Earthquake Victims
|
MT
| |
24-12-19 |
Northeast Pharmaceutical Gets Nod to Market Empagliflozin
|
MT
| |
24-11-18 |
Northeast Pharmaceutical Group Co., Ltd. Completed the acquisition of 70% stake in Beijing Dingcheng Taiyuan Biotechnology Co., Ltd. from Zhang Rong and others.
|
CI
| |
24-11-06 |
Northeast Pharmaceutical Group Acquiring 70% Stake in Dingcheng Peptide Source; Shares Up 10%
|
MT
| |
24-10-23 |
Northeast Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2024
|
CI
| |
24-08-27 |
Northeast Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2024
|
CI
|
No results match your criteria Select your edition All financial news and data tailored to specific country editions | 
